金双歧思密达联用治疗小儿腹泻80例的的疗效观察.docVIP

金双歧思密达联用治疗小儿腹泻80例的的疗效观察 　　[摘要] 目的：探讨金双歧、思密达联用治疗小儿腹泻的临床效果。方法：选择2010年1～5月在我院治疗的80例腹泻患儿，随机分为治疗组和对照组，对照组给予常规治疗，治疗组在常规治疗的基础上加用金双歧、思密达口服，比较两组疗效。结果：治疗组治愈率为75.0%，好转率为17.5%，总有效率为92.5%；对照组治愈率为55.0%，好转率为20.0%，总有效率为75.0%；两组比较，差异有统计学意义(P＜0.05)，治疗组疗效优于对照组。结论：金双歧、思密达联用治疗小儿腹泻效果显著，值得临床推广应用。 　　[关键词] 金双歧；思密达；腹泻 　　[中图分类号] R725.7[文献标识码]B [文章编号]1673-7210（2010）11（a）-059－０2 　　 　　Efficacy observation of Golden bifid and Smecta in the treatment of 80 children with diarrhea 　　GUAN Zhidong 　　(The Maternity and Child Care Centers of Yuzhou Area, Yulin City, Guangxi Province, Yulin 537000, China) 　　[Abstract] Objective: To investigate the clinical effect of Golden bifid and Smecta in the treatment of children with diarrhea. Methods: From January to May 2010 in our hospital, 80 children with diarrhea were randomly divided into treatment group and control group, the control group with conventional treatment, the observation group added Golden bifid and Smecta on the basis of the conventional therapy, the clinical effects of two groups were compared. Results: In the treatment group，the cure rate was 75.0%, the improvement rate was 17.5%, the total effective rate was 92.5%; in the control group, the cure rate was 55.0%, the improvement rate was 20.0% and the total effective rate was 75.0%; the difference were statistically significant (P＜0.05), the clinical effect of treatment group was better than the control group. Conclusion: Golden bifid and Smecta in the treatment of children with diarrhea has significant effect, it is worth of clinical application. 　　[Key words] Golden bifid; Smecta; Diarrhea 　　 　　小儿腹泻是一种消化道综合征，也称为轮状病毒性肠炎，多发于2岁以下的婴幼儿，表现为大便次数增多和大便性状改变，临床上常有恶心、呕吐、发热、腹痛等症状，易引起脱水和电解质紊乱，是造成小儿营养不良和生长发育障碍的主要原因之一[1]，因此及时发现和治疗对维护小儿健康有积极意义。我院联合应用金双歧和思密达治疗小儿腹泻，取得较为满意的效果，报道如下： 　　1资料与方法 　　1.1 一般资料 　　本组80例腹泻患儿，于2010年1～5月在我院门诊及住院治疗，其中，男44例，女36例；年龄最小7个月，最大4岁，平均22个月；全部患儿急性发病，病程均在3 d以内，每日大便次数在5次以上，大便呈黄色或黄绿色稀水或蛋花汤样，含有少量黏液；患儿均有脱水表现，其中，轻度53例，中度27例；大便镜检无红细胞和脓球，多数为脂肪细胞，可见少数白细胞。患儿诊断依据“中国腹泻病诊断治疗方案”的诊断标准